SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19760551
Source:
http://linkedlifedata.com/resource/pubmed/id/19760551
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0032743
,
umls-concept:C0336791
,
umls-concept:C0681842
,
umls-concept:C1261473
,
umls-concept:C1518681
pubmed:issue
39
pubmed:dateCreated
2009-9-17
pubmed:abstractText
We used 2-deoxy-2-[(18)F] fluoro-D-glucose (FDG) positron emission tomography (PET) to evaluate the FDG uptake in patients with soft tissue sarcoma (STS). Treatment effect was assessed with regard to prediction of therapy outcome.
pubmed:language
ger
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0006723
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin
,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide
,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyglucose F18
,
http://linkedlifedata.com/resource/pubmed/chemical/Ifosfamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1439-4413
pubmed:author
pubmed-author:EgererGG
,
pubmed-author:HoA DAD
,
pubmed-author:KasperBB
,
pubmed-author:SchmittTT
,
pubmed-author:WuchterPP
pubmed:copyrightInfo
Georg Thieme Verlag KG Stuttgart, New York.
pubmed:issnType
Electronic
pubmed:volume
134
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1922-6
pubmed:meshHeading
pubmed-meshheading:19760551-Adult
,
pubmed-meshheading:19760551-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:19760551-Disease Progression
,
pubmed-meshheading:19760551-Doxorubicin
,
pubmed-meshheading:19760551-Etoposide
,
pubmed-meshheading:19760551-Female
,
pubmed-meshheading:19760551-Fluorodeoxyglucose F18
,
pubmed-meshheading:19760551-Humans
,
pubmed-meshheading:19760551-Ifosfamide
,
pubmed-meshheading:19760551-Male
,
pubmed-meshheading:19760551-Middle Aged
,
pubmed-meshheading:19760551-Positron-Emission Tomography
,
pubmed-meshheading:19760551-Radiopharmaceuticals
,
pubmed-meshheading:19760551-Remission Induction
,
pubmed-meshheading:19760551-Sarcoma
,
pubmed-meshheading:19760551-Soft Tissue Neoplasms
,
pubmed-meshheading:19760551-Treatment Outcome
,
pubmed-meshheading:19760551-Young Adult
pubmed:year
2009
pubmed:articleTitle
[Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma].
pubmed:affiliation
Abteilung Innere Medizin V (Hämatologie, Onkologie und Rheumatologie), Medizinische Klinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg. mail@berndkasper.de
pubmed:publicationType
Journal Article
,
English Abstract
,
Case Reports
,
Evaluation Studies